Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gracell Biotechnologies Inc ADR (NQ: GRCL ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Feb 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 10.22 (49) Ask (Size) 10.41 (10) Prev. Close 10.25 Today's Range N/A - N/A 52wk Range 3.800 - 10.44 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Gracell Biotechnologies Acquisition Completed February 22, 2024 From Gracell Biotechnologies Inc. Via GlobeNewswire Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement February 20, 2024 From Gracell Biotechnologies Inc. Via GlobeNewswire Performance More News Read More Gracell Biotechnologies Inc. (NASDAQ: GRCL) is a Stock Spotlight on 2/7 February 07, 2024 Via Investor Brand Network Health Care Company AstraZeneca Announces Acquisition of Gracell Biotechnologies December 26, 2023 Via Benzinga Week In Review: Shanghai Inmagene Signs $230 Million Deal To Develop Two HutchMed Immunology Assets February 03, 2024 Via Talk Markets Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma January 29, 2024 From Gracell Biotechnologies Inc. Via GlobeNewswire Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment January 23, 2024 Via Benzinga Exposures Product Safety BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP) January 16, 2024 From Brodsky & Smith LLC Via GlobeNewswire AstraZeneca: Rebound in 2024 with double-digit earnings growth January 11, 2024 Via MarketBeat Exposures COVID-19 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP) January 08, 2024 From Brodsky & Smith LLC Via GlobeNewswire With its sale to AstraZeneca, Gracell blazes exit trail for cash-challenged Chinese biotechs January 05, 2024 Via Benzinga Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 January 05, 2024 Via Investor's Business Daily BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX) January 04, 2024 From Brodsky & Smith LLC Via GlobeNewswire GRACELL BIOTECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Gracell Biotechnologies Inc. - GRCL December 31, 2023 From Kahn Swick & Foti, LLC Via Business Wire Week In Review: $1.7 Billion Collaboration Between Elpiscience And Astellas Is Final 2023 Deal December 31, 2023 Via Talk Markets Stock Market Ending 2023 On High Note; Tesla, Drug M&A In Focus: Weekly Review December 29, 2023 Via Investor's Business Daily Topics Stocks Exposures US Equities Investor Sentiment Improves; Dow Jumps Over 150 Points December 27, 2023 Via Benzinga Topics Stocks Exposures US Equities BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX) December 26, 2023 From Brodsky & Smith LLC Via GlobeNewswire Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher December 26, 2023 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Tuesday's Intraday Session December 26, 2023 Via Benzinga Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session December 26, 2023 Via Benzinga Crude Oil Rises Over 3%; US Home Prices Increase In October December 26, 2023 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 12 Health Care Stocks Moving In Tuesday's Pre-Market Session December 26, 2023 Via Benzinga Why Sentage Holdings Shares Are Trading Lower By 5%; Here Are 20 Stocks Moving Premarket December 26, 2023 Via Benzinga US Stocks Set To Start Final Trading Week Of Year On Positive Note As Santa Claus Rally Gets Going: Analyst Confident Of Market Finishing Year At Highs December 26, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
